Structures by: Ochoa P.
Total: 6
<i>N</i>^4^-(2-Aminophenyl)-6-methoxy-5-nitrosopyrimidine-2,4-diamine
C25H22N6O
Acta Crystallographica Section C (2019) 75, 10
a=9.7167(10)Å b=16.1179(17)Å c=13.9936(16)Å
α=90° β=91.395(4)° γ=90°
6-Methoxy-<i>N</i>^5^-(4-methoxybenzyl)-4-[2-(4-methoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine
C27H26N6O3
Acta Crystallographica Section C (2019) 75, 10
a=15.8911(13)Å b=9.6209(7)Å c=15.9244(11)Å
α=90° β=91.581(3)° γ=90°
6-Methoxy-4-[2-(4-methylphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine monohydrate
C19H18N6O,H2O
Acta Crystallographica Section C (2019) 75, 10
a=8.1992(7)Å b=11.0160(8)Å c=11.4240(9)Å
α=109.105(3)° β=109.171(3)° γ=97.138(3)°
6-Methoxy-<i>N</i>^5^-(4-nitrobenzyl)-4-[2-(4-nitrophenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine
C25H20N8O5
Acta Crystallographica Section C (2019) 75, 10
a=7.6614(6)Å b=16.6048(11)Å c=18.1311(13)Å
α=90° β=97.101(3)° γ=90°
<i>N</i>-{2-Amino-6-methoxy-4-[2-(4-methylphenyl)-1<i>H</i>-\ benzo[<i>d</i>]imidazol-1-yl]pyrimidin-5-yl}-2,2,2-trifluoroacetamide
C21H17F3N6O2,CH4O
Acta Crystallographica Section C (2019) 75, 10
a=12.6296(8)Å b=11.2206(7)Å c=15.6480(10)Å
α=90° β=104.180(2)° γ=90°
<i>N</i>-{5-Amino-6-methoxy-6-[2-(4-methylphenyl)-1<i>H</i>-\ benzo[<i>d</i>]imidazol-1-yl]pyrimidin-2-yl}-2,2,2-trifluoroacetamide ethyl acetate monosolvate
C21H17F3N6O2,C4H8O2
Acta Crystallographica Section C (2019) 75, 10
a=9.1818(8)Å b=21.0771(16)Å c=13.3610(11)Å
α=90° β=91.777(3)° γ=90°